Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet

Clinical Science

Volumn 119, Issue 6, 2010, Pages 239-250

  Souza Mello, Vanessa ^a   Gregório, Bianca M ^a   Cardoso De Lemos, Fernando S ^a   De Carvalho, Laís ^a   Aguila, Márcia B ^a   Mandarim De Lacerda, Carlos A ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Angiotensin II type 1 receptor blocker (ARB); Dipeptidyl peptidase IV inhibitor (DPP IV inhibitor); Insulin resistance; Metabolic syndrome; Metformin; Non alcoholic fatty liver disease (NAFLD)

Indexed keywords

ADIPOCYTOKINE; CARBOHYDRATE; GLUCOSE TRANSPORTER 2; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SITAGLIPTIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; TELMISARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; PYRAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CALORIC INTAKE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE INTOLERANCE; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIPID DIET; MALE; MONOTHERAPY; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEATOSIS; WESTERN BLOTTING; ADIPOCYTE; ANIMAL; C57BL MOUSE; DRUG COMBINATION; DRUG SCREENING; FAT INTAKE; GLUCOSE TOLERANCE TEST; LIVER; METABOLIC SYNDROME X; METHODOLOGY; PANCREAS; PATHOLOGY; PATHOPHYSIOLOGY; ULTRASTRUCTURE;

ADIPOCYTES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BENZOATES; DIETARY FATS; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; ENERGY INTAKE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; METFORMIN; MICE; MICE, INBRED C57BL; OBESITY; PANCREAS; PYRAZINES; TRIAZOLES;

EID: 77956051448     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100061     Document Type: Article

References (39)

1. Despres, J. P. and Lemieux, I. (2006) Abdominal obesity and metabolic syndrome. Nature 444, 881-887
2. Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G. and Melchionda, N. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50, 1844-1850 (Pubitemid 33641605)
3. Pitt, H. A. (2007) Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB 9, 92-97 (Pubitemid 46672381)
4. Duvnjak, M., Lerotic, I., Barsic, N., Tomasic, V., Virovic Jukic, L. and Velagic, V. (2007) Pathogenesis and management issues for non-alcoholic fatty liver disease. World J. Gastroenterol. 13, 4539-4550
5. Pershadsingh, H. A. (2006) Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-γ. Int. J. Biochem. Cell Biol. 38, 766-781
6. Home, P. D. and Pacini, G. (2008) Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents. Diabetes Obes. Metab. 10, 699-718
7. Ranganath, L. R. (2008) Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1. J. Clin. Pathol. 61, 401-409
8. Gallou-Kabani, C., Vige, A., Gross, M. S., Rabes, J. P., Boileau, C., Larue-Achagiotis, C., Tome, D., Jais, J. P. and Junien, C. (2007) C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity 15, 1996-2005 (Pubitemid 47402231)
9. Schreyer, S. A., Wilson, D. L. and LeBoeuf, R. C. (1998) C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis 136, 17-24
10. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419
11. Mandarim-de-Lacerda, C. A., Fernandes-Santos, C. and Aguila, M. B. (2010) Image analysis and quantitative morphology. Methods Mol. Biol. 611, 211-225
12. Aguila, M. B., Pinheiro, A. R., Parente, L. B. and Mandarim-de-Lacerda, C. A. (2003) Dietary effect of different high-fat diet on rat liver stereology. Liver Int. 23, 363-370
13. Gundersen, H. J. (1977) Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microsc. 111, 219-227
14. Fernandes-Santos, C., Carneiro, R. E., Mendonca, L. S., Aguila, M. B. and Mandarim-de-Lacerda, C. A. (2009) Rosiglitazone aggravates nonalcoholic fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas 38, e80-e86
15. Mandarim-de-Lacerda, C. A. (2003) Stereological tools in biomedical research. An. Acad. Bras. Cienc. 75, 469-486
16. Araki, K., Masaki, T., Katsuragi, I., Tanaka, K., Kakuma, T. and Yoshimatsu, H. (2006) Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension 48, 51-57 (Pubitemid 44297524)
17. Cohen, S. E., Tseng, Y. H., Michael, M. D. and Kahn, C. R. (2004) Effects of insulin-sensitising agents in mice with hepatic insulin resistance. Diabetologia 47, 407-411
18. Lamont, B. J. and Drucker, D. J. (2008) Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice. Diabetes 57, 190-198
19. Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A. and Kurtz, T. W. (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity. Hypertension 43, 993-1002
20. Zanchi, A., Dulloo, A. G., Perregaux, C., Montani, J. P. and Burnier, M. (2007) Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties. Am. J. Physiol. Endocrinol. Metab. 293, E91-E95
21. Yasuda, N., Inoue, T., Nagakura, T., Yamazaki, K., Kira, K., Saeki, T. and Tanaka, I. (2002) Enhanced secretion of glucagon-like peptide 1 by biguanide compounds. Biochem. Biophys. Res. Commun. 298, 779-784
22. Green, B. D., Irwin, N., Duffy, N. A., Gault, V. A., O'Harte F, P. and Flatt, P. R. (2006) Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1. Eur. J. Pharmacol. 547, 192-199
23. Goodarzi, M. O. and Bryer-Ash, M. (2005) Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes. Metab. 7, 654-665
24. Baggio, L. L. and Drucker, D. J. (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157
25. Herman, G. A., Bergman, A., Yi, B. and Kipnes, M. (2006) Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes. Curr. Med. Res. Opin. 22, 1939-1947
26. Festi, D., Colecchia, A., Sacco, T., Bondi, M., Roda, E. and Marchesini, G. (2004) Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes. Rev. 5, 27-42
27. Geerts, A. (2001) History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells. Semin. Liver Dis. 21, 311-335
28. Hui, A. Y. and Friedman, S. L. (2003) Molecular basis of hepatic fibrosis. Expert Rev. Mol. Med. 5, 1-23
29. Friedman, S. L. (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669
30. Svegliati-Baroni, G., Candelaresi, C., Saccomanno, S., Ferretti, G., Bachetti, T., Marzioni, M., De Minicis, S., Nobili, L., Salzano, R., Omenetti, A. et al. (2006) A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-α and n-3 polyunsaturated fatty acid treatment on liver injury. Am. J. Pathol. 169, 846-860
31. Nabeshima, Y., Tazuma, S., Kanno, K., Hyogo, H. and Chayama, K. (2009) Deletion of angiotensin II type I receptor reduces hepatic steatosis. J. Hepatol. 50, 1226-1235
32. Ibdah, J. A., Perlegas, P., Zhao, Y., Angdisen, J., Borgerink, H., Shadoan, M. K., Wagner, J. D., Matern, D., Rinaldo, P. and Cline, J. M. (2005) Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 128, 1381-1390
33. Petersen, K. F. and Shulman, G. I. (2006) Etiology of insulin resistance. Am. J. Med. 119, S10-S16
34. Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D. et al. (2008) Interleukin-6 regulates pancreatic α-cell mass expansion. Proc. Natl. Acad. Sci. U.S.A. 105, 13163-13168
35. Winzell, M. S., Brand, C. L., Wierup, N., Sidelmann, U. G., Sundler, F., Nishimura, E. and Ahren, B. (2007) Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet. Diabetologia 50, 1453-1462
36. Sharma, A. M., Janke, J., Gorzelniak, K., Engeli, S. and Luft, F. C. (2002) Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 40, 609-611
37. Kudo, H., Yata, Y., Takahara, T., Kawai, K., Nakayama, Y., Kanayama, M., Oya, T., Morita, S., Sasahara, M., Mann, D. A. et al. (2009) Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. Liver Int. 27, 988-996.
38. Ren, T., He, J., Jiang, H., Zu, L., Pu, S., Guo, X. and Xu, G. (2006) Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-α or isoproterenol. J. Mol. Endocrinol. 37, 175-183
39. Boschmann, M., Engeli, S., Dobberstein, K., Budziarek, P., Strauss, A., Boehnke, J., Sweep, F. C., Luft, F. C., He, Y., Foley, J. E. et al. (2009) Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 94, 846-852